Verition Fund Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $362K | Sell |
3,011
-19,479
| -87% | -$2.25M | ﹤0.01% | 1704 |
|
|
2025
Q4 | $2.37M | Sell |
22,490
-83,099
| -79% | -$7.8M | 0.01% | 1452 |
|
|
2025
Q3 | $8.86M | Buy |
105,589
+1,591
| +2% | +$131K | 0.04% | 610 |
|
|
2025
Q2 | $8.23M | Buy |
103,998
+34,510
| +50% | +$2.74M | 0.04% | 649 |
|
|
2025
Q1 | $6.24M | Sell |
69,488
-19,493
| -22% | -$1.82M | 0.03% | 693 |
|
|
2024
Q4 | $8.85M | Sell |
88,981
-24,062
| -21% | -$2.48M | 0.04% | 584 |
|
|
2024
Q3 | $12.8M | Buy |
113,043
+46,926
| +71% | +$5.58M | 0.06% | 294 |
|
|
2024
Q2 | $8.19M | Buy |
66,117
+27,584
| +72% | +$3.55M | 0.04% | 448 |
|
|
2024
Q1 | $5.08M | Sell |
38,533
-6,860
| -15% | -$846K | 0.03% | 662 |
|
|
2023
Q4 | $4.95M | Sell |
45,393
-47,597
| -51% | -$4.94M | 0.04% | 448 |
|
|
2023
Q3 | $9.57M | Buy |
92,990
+83,633
| +894% | +$9.01M | 0.11% | 231 |
|
|
2023
Q2 | $1.08M | Buy |
9,357
+2,377
| +34% | +$270K | 0.01% | 909 |
|
|
2023
Q1 | $743K | Sell |
6,980
-3,050
| -30% | -$329K | 0.01% | 1062 |
|
|
2022
Q4 | $1.11M | Sell |
10,030
-21,781
| -68% | -$2.23M | 0.02% | 870 |
|
|
2022
Q3 | $2.74M | Buy |
31,811
+16,445
| +107% | +$1.47M | 0.03% | 715 |
|
|
2022
Q2 | $1.4M | Buy |
15,366
+4,947
| +47% | +$439K | 0.03% | 852 |
|
|
2022
Q1 | $855K | Sell |
10,419
-12,271
| -54% | -$967K | 0.01% | 1584 |
|
|
2021
Q4 | $1.74M | Sell |
22,690
-148,594
| -87% | -$11.8M | 0.01% | 970 |
|
|
2021
Q3 | $12.9M | Buy |
171,284
+167,914
| +4,983% | +$12.8M | 0.11% | 124 |
|
|
2021
Q2 | $262K | Sell |
3,370
-572
| -15% | -$42.5K | ﹤0.01% | 1415 |
|
|
2021
Q1 | $290K | Sell |
3,942
-103,711
| -96% | -$7.65M | ﹤0.01% | 1143 |
|
|
2020
Q4 | $8.4M | Sell |
107,653
-42,525
| -28% | -$3.25M | 0.07% | 148 |
|
|
2020
Q3 | $11.9M | Buy |
150,178
+101,166
| +206% | +$7.92M | 0.24% | 70 |
|
|
2020
Q2 | $3.62M | Buy |
+49,012
| New | +$3.69M | 0.12% | 139 |
|
|
2020
Q1 | – | Sell |
-26,780
| Closed | -$2.1M | – | 894 |
|
|
2019
Q4 | $2.32M | Sell |
26,780
-21,501
| -45% | -$1.77M | 0.04% | 247 |
|
|
2019
Q3 | $3.88M | Buy |
48,281
+19,011
| +65% | +$1.52M | 0.11% | 132 |
|
|
2019
Q2 | $2.34M | Sell |
29,270
-191,731
| -87% | -$14.7M | 0.07% | 211 |
|
|
2019
Q1 | $17.5M | Buy |
+221,001
| New | +$16.5M | 0.68% | 21 |
|
|
2018
Q3 | – | Sell |
-13,938
| Closed | -$807K | – | 1378 |
|
|
2018
Q2 | $807K | Sell |
13,938
-72,481
| -84% | -$4.09M | 0.05% | 497 |
|
|
2018
Q1 | $4.49M | Buy |
86,419
+74,650
| +634% | +$4.03M | 0.33% | 53 |
|
|
2017
Q4 | $632K | Sell |
11,769
-17,461
| -60% | -$968K | 0.06% | 402 |
|
|
2017
Q3 | $1.79M | Buy |
29,230
+18,770
| +179% | +$1.14M | 0.14% | 134 |
|
|
2017
Q2 | $640K | Sell |
10,460
-7,557
| -42% | -$460K | 0.06% | 330 |
|
|
2017
Q1 | $1.09M | Sell |
18,017
-35,247
| -66% | -$2.14M | 0.1% | 224 |
|
|
2016
Q4 | $2.99M | Buy |
+53,264
| New | +$3.12M | 0.26% | 58 |
|
|
2014
Q4 | – | Sell |
-13,689
| Closed | -$774K | – | 551 |
|
|
2014
Q3 | $774K | Sell |
13,689
-19,439
| -59% | -$1.09M | 0.11% | 148 |
|
|
2014
Q2 | $1.83M | Buy |
+33,128
| New | +$1.81M | 0.2% | 68 |
|
|
2014
Q1 | – | Sell |
-7,176
| Closed | -$343K | – | 598 |
|
|
2013
Q4 | $343K | Sell |
7,176
-11,575
| -62% | -$529K | 0.06% | 240 |
|
|
2013
Q3 | $852K | Buy |
18,751
+2,745
| +17% | +$125K | 0.13% | 131 |
|
|
2013
Q2 | $709K | Buy |
+16,006
| New | +$715K | 0.13% | 147 |
|
Other funds holding MRK
VCM
VPM
Verition Fund Management's MRK Position: Q1 2026 in Review
Verition Fund Management reduced its Merck (MRK) stake by 87% in Q1 2026, selling an estimated $2.25M and leaving 3,011 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.
Verition Fund Management first reported a position in MRK in Q2 2013 and has held it in 40 quarters since. The position peaked at $17.5M in Q1 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Verition Fund Management held 3,011 shares of Merck worth $362K as of Q1 2026.
- Verition Fund Management sold 19,479 Merck shares in Q1 2026, an estimated $2.25M.
- Merck made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1704 holding.
- Verition Fund Management first reported a position in Merck in Q2 2013 and has held it in 40 quarters since.
- Verition Fund Management's Merck position peaked at $17.5M in Q1 2019.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.